A comprehensive view of Bausch Health Canada Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Bausch Health and its dermatology business, Ortho Dermatologics, announce FDA approval for Cabtreo Topical Gel 1.2%/0.15%/3.1%, for the topical treatment of acne vulgaris in patients twelve years of age and older
Published: October 23, 2023 by ENP Newswire
Enviri appoints Tom Vadaketh as CFO; Vadaketh brings more than 30 years of financial experience, most recently serving as CFO of Bausch Health, a US$4.5B pharmaceutical, medical aesthetics company
Published: September 21, 2023 by Enviri Corp.
Bausch Health Canada recalls all lots of its Emerade epinephrine auto-injectors in 0.3 mg and 0.5 mg strengths due to possible device failure; Bausch distributed the affected lots in Canada between April 2022 and May 2023
Published: May 08, 2023 by Cision

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count